Table 1.
Type of presentation |
KDSS in this study (n = 6) |
KDSS worldwide (n = 106) (19) |
MIS-C (n = 655) (24) |
---|---|---|---|
Age at onset | 3.5 (3–12 y) | 5.0 y | 8 (3 mo−20 y) |
Sex | |||
Male (%) | 50% | 55% | 55% |
Hospital stay, d | 6 (4–6) | mean 7.2 | 4 (3–6) |
Clinical Symptoms | |||
Fever | 100% | 100% | 100% |
Gastrointestinal | 87% | 75% | 70% |
Cardiovascular | 100% | 50% | 51% |
Neurologic | 0% | 54% | 22% |
Skin rash | 100% | ND | 58% |
Respiratory | 0% | 32% | 9.6% |
Renal | 13% | 46% | ND |
Met KD criteria | 100% | 70% | 6.2% |
Treatment and outcome | |||
Inotropes | 67% | 67% | 45% |
Invasive mechanical ventilation | 0% | 28% | 20% |
Death | 0% | 6.7% | 1.7% |